Published on
February 11, 2021
- 20:29 GMT
L2Mtech GmbH Receives CE Mark Approval on 6 (SIX) products for Cardiovascular and Endovascular Applications
CE Mark Approval for LimusTrack™; LomiFlow™; PearlFlow™; PearlFlow NS™; FlexiTrack 018™ and FlexiTrack 035™ for Cardiovascular and Endovascular Applications BONN, NRW, GERMANY, February 11, 2021 /EINPresswire.com/ -- L2Mtech GmbH Founder and CEO Lalit …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
